Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ji Won Chae"'
Publikováno v:
Korean Journal of Clinical Laboratory Science, Vol 54, Iss 1, Pp 61-67 (2022)
Intraoperative neurophysiological monitoring (INM) ensures the stability and safety of specific surgeries in high-risk groups. As part of INM, intensive tests are conducted during the surgical process. When INM tests are applied during surgery, a d
Externí odkaz:
https://doaj.org/article/9c70934585b346f9a1491da10116683a
Publikováno v:
The Journal of Internal Korean Medicine. 41:132-140
Autor:
Ji-Won Chae
Publikováno v:
THE JOURNAL OF HUMANITIES STUDIES. 118:5-26
Autor:
Sohee Kim, Hyun Woo Jang, Hyeokjin Kwon, Su Jin Heo, Goeun Pyo, Dong Su Kim, Ji Won Chae, Jae Eun Jang
Publikováno v:
2021 IEEE Sensors.
Publikováno v:
Journal of Controlled Release. 215:82-90
Effective intracellular level of a platinum anti-cancer drug, cisplatin, following repeated injections can be decreased either by the active efflux via ATP pump or by interactions with glutathione and metallothionein. Cisplatin in cytoplasm preferabl
Dual-mode enhancement of metallothionein protein with cell transduction and retention peptide fusion
Autor:
Kwang Suk Lim, Yong-Hee Kim, Myoung Hwa Lim, Seong Eon Ryu, Jang Kyoung Kim, Young Cheol Kang, Ji Won Chae, So Mi Kim, Youngmi Kim Pak, Young-Wook Won, Eun Jeong Park
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 171(2)
Protein transduction domains (PTDs), also known as cell-penetrating peptides (CPPs), have been developed as effective systems for delivering bio-active cargos such as proteins, genes and particles. Further improvements on cell-specific targeting, int
Autor:
Yong-Hee Kim, Jang Kyoung Kim, Min Ji Cha, Kwang Suk Lim, Ji Won Chae, Taiyoun Rhim, Ki-Chul Hwang, Eun Jeong Park
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 169(3)
Ischemic heart diseases caused by insufficient oxygen supply to the cardiac muscle require pharmaceutical agents for the prevention of the progress and recurrence. Metallothionein (MT) has a potential as a protein therapeutic for the treatment of thi